Cargando…
Clinical and metabolic consequences of L-serine supplementation in hereditary sensory and autonomic neuropathy type 1C
Hereditary sensory neuropathy type 1 (HSAN1) may be the first genetic neuropathy amenable to a specific mechanism-based treatment, as L-serine supplementation can be used to lower the neurotoxic levels of 1-deoxysphingolipids (1-deoxySL) that cause the neurodegeneration. The treatment is so far unte...
Autores principales: | Auranen, Mari, Toppila, Jussi, Suriyanarayanan, Saranya, Lone, Museer A., Paetau, Anders, Tyynismaa, Henna, Hornemann, Thorsten, Ylikallio, Emil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701299/ https://www.ncbi.nlm.nih.gov/pubmed/29042446 http://dx.doi.org/10.1101/mcs.a002212 |
Ejemplares similares
-
CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease
por: Auranen, Mari, et al.
Publicado: (2015) -
Randomized trial of l-serine in patients with hereditary sensory and autonomic neuropathy type 1
por: Fridman, Vera, et al.
Publicado: (2019) -
Truncated HSPB1 causes axonal neuropathy and impairs tolerance to unfolded protein stress
por: Ylikallio, Emil, et al.
Publicado: (2015) -
Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy
por: Sainio, Markus T., et al.
Publicado: (2018) -
An iPSC model of hereditary sensory neuropathy-1 reveals L-serine-responsive deficits in neuronal ganglioside composition and axoglial interactions
por: Clark, Alex J., et al.
Publicado: (2021)